As the use of GLP-1s, like Ozempic, has skyrocketed in the U.S., two researchers at UMass Chan Medical School in Worcester have received a $2 million award from the Centers for Disease Control and Prevention to study lifestyle change of those taking the popular drug.
Six months after she assumed the role of interim CEO of the Hospital for Behavioral Medicine, Rachel Corus has dropped her interim tag, making her the Worcester hospital’s fourth permanent CEO in six years.
Resident physicians have voted to ratify a new contract with UMass Chan Medical School in Worcester, including a nearly 10% raise and thousands of dollars in mental health and education benefits.
The BOB awards recognize the best business-to-business companies in Central Massachusetts: those dedicated to excellence and delivering exceptional products.